Moderna CEO eyes August timeline to ship COVID variant vaccine upon approval - Reuters
Gabriel Kuchta/Getty Images News


Moderna's (NASDAQ:MRNA) new COVID-19 variant vaccine will be ready for dispatch in August, even as the company is still filing the data for approval, Reuters reported citing CEO Stephane Bancel.
The Cambridge, Mass.-based company has been making vaccine ahead of a potential approval in August.

Bancel told the news agency that Moderna will file all the data by June end and is hoping that by August the vaccine gets an authorization.
Bancel added that the main obstacle was regulatory, as the company is already making the vaccine from a manufacturing standpoint. The company will be able to dispatch the vaccines in August and to some countries in September but it would depend upon regulatory decision, the report added.